We are live on ! Find out more

1,913 hedge funds and large institutions have $120B invested in Merck in 2016 Q4 according to their latest regulatory filings, with 205 funds opening new positions, 748 increasing their positions, 735 reducing their positions, and 77 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more first-time investments, than exits

New positions opened: 205 | Existing positions closed: 77

5% more funds holding

Funds holding: 1,8151,913 (+98)

2% more repeat investments, than reductions

Existing positions increased: 748 | Existing positions reduced: 735

0.64% less ownership

Funds ownership: 78.18%77.55% (-0.64%)

6% less capital invested

Capital invested by funds: $127B → $120B (-$7.25B)

15% less call options, than puts

Call options by funds: $1.26B | Put options by funds: $1.47B

31% less funds holding in top 10

Funds holding in top 10: 174120 (-54)

Holders
1,913
Holders Change
+98
Holders Change %
+5.4%
% of All Funds
47.81%
Holding in Top 10
120
Holding in Top 10 Change
-54
Holding in Top 10 Change %
-31.03%
% of All Funds
3%
New
205
Increased
748
Reduced
735
Closed
77
Calls
$1.26B
Puts
$1.47B
Net Calls
-$215M
Net Calls Change
-$53.5M
Name Holding Trade Value Shares
Change
Change in
Stake
CAM
1351
Cubic Asset Management
Massachusetts
$762K +$5.21K +89 +0.7%
WSC
1352
Wellington Shields & Co
New York
$761K
HAIM
1353
Hunter Associates Investment Management
Pennsylvania
$760K +$33.5K +573 +4%
SM
1354
Sciencast Management
New Jersey
$760K +$792K +13,525 New
CCC
1355
Chelsea Counsel Company
California
$757K +$7.72K +132 +1%
CCMG
1356
Clark Capital Management Group
Pennsylvania
$756K
MPAM
1357
Murphy Pohlad Asset Management
Minnesota
$754K -$47.5K -812 -6%
FFC
1358
First Financial Corp
Indiana
$749K -$76.4K -1,306 -9%
NG
1359
Northstar Group
New York
$749K +$9.48K +162 +1%
FMW
1360
Farr Miller & Washington
District of Columbia
$747K -$47.2K -807 -6%
BEC
1361
Blue Edge Capital
Virginia
$744K
VC
1362
Vicus Capital
Pennsylvania
$732K +$21.9K +374 +3%
BIM
1363
Barton Investment Management
Pennsylvania
$731K
PP
1364
Pegasus Partners
Wisconsin
$729K +$39.4K +674 +5%
ID
1365
Integral Derivatives
New York
$727K -$1.08M -18,487 -59%
FAM
1366
Fred Alger Management
New York
$725K -$1.03M -17,659 -58%
NPT
1367
Nixon Peabody Trust
Massachusetts
$725K -$123K -2,096 -14%
HKIM
1368
Hayek Kallen Investment Management
Alabama
$725K -$9.71K -166 -1%
PCMM
1369
Private Capital Management (Minnesota)
Minnesota
$724K -$319K -5,450 -30%
SCM
1370
Stonebridge Capital Management
California
$722K +$138K +2,358 +22%
EGA
1371
E&G Advisors
Texas
$719K -$91.6K -1,566 -11%
LKIM
1372
Lawson Kroeker Investment Management
Nebraska
$719K
CAG
1373
Crestwood Advisors Group
Massachusetts
$719K +$44.1K +754 +6%
DAM
1374
Delta Asset Management
Tennessee
$717K
SFWA
1375
Summit Financial Wealth Advisors
Louisiana
$717K +$5.27K +90 +0.7%

MRK Hedge Fund Activity: Q4 2016 in Review

1,913 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2016, worth a combined $120B — down 5.7% from $127B a quarter earlier.

Buyers outnumbered sellers: 205 funds opened new MRK positions and 77 closed out — a net gain of 128 holders — while 748 added to existing stakes and 735 trimmed.

The largest buyer was Capital World Investors, adding an estimated $620M. The largest seller was Wellington Management Group, cutting an estimated $1.63B.

  • 1,913 institutional investors held Merck (MRK) as of Q4 2016, up from 1,815 in Q3 2016.
  • Funds reported $120B of Merck stock for Q4 2016, down 5.7% quarter-over-quarter.
  • 205 funds opened new Merck positions in Q4 2016 and 77 closed out, a net change of +128 holders.
  • The largest Merck buyer in Q4 2016 was Capital World Investors, an estimated $620M added.
  • The largest Merck seller in Q4 2016 was Wellington Management Group, an estimated $1.63B sold.

Based on aggregated 13F filings for Q4 2016.